Gómez-Ambrosi, J
Andrada, P
Valentí, V
Rotellar, F
Silva, C
Catalán, V
Rodríguez, A
Ramírez, B
Moncada, R
Escalada, J
Salvador, J
Frühbeck, G
Article History
Received: 10 March 2017
Revised: 15 May 2017
Accepted: 25 May 2017
First Online: 6 June 2017
Competing interests
: G Frühbeck has served as an advisor for Novo Nordisk Pharmaceuticals. The remaining authors declare no conflict of interest.